Literature DB >> 17728609

Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study.

Michael Hentschel1, Timo Paulus, Michael Mix, Ernst Moser, Egbert U Nitzsche, Ingo Brink.   

Abstract

OBJECTIVE: To determine parameters of perfusion, distribution coefficient, and glucose metabolism as part of the tumour-specific micromilieu of breast cancer and compare them with corresponding values in normal breast tissue.
METHODS: H2(15)O PET and 18F-FDG PET were performed on 10 patients with advanced invasive ductal carcinomas of the breast. Perfusion, distribution coefficient, and glucose metabolism and standardized uptake were quantified and analysed.
RESULTS: Mean values based on the regions of interest were 59.2+/-43.9 ml x min(-1) x 100 g(-1) (perfusion), 0.58+/-0.26 ml x g(-1) (distribution coefficient), 7.76+/-6.10 (standardized uptake), and 5.4+/-2.5 mg x min(-1) x 100 g(-1) (glucose metabolism). The corresponding values for normal breast tissue were 22.1+/-13.2 ml x min x 100 g(-1) (perfusion), 0.16+/-0.05 ml x g(-1) (distribution coefficient), 0.33+/-0.07 (standardized uptake), and 0.18+/-0.08 mg x min x 100 g(-1) (glucose metabolism). For each tumour-normal tissue parameter pair, the mean values were significantly higher in tumours than normal breast tissue. Region-of-interest and pixel-wise correlation analysis revealed a positive association between glucose metabolism and distribution coefficient and glucose metabolism and perfusion for 7/10 tumours investigated.
CONCLUSIONS: H2(15)O PET and 18F-FDG PET were able to differentiate breast cancer and normal breast tissue. The pixel-wise analysis revealed information about the heterogeneity of tumour fine structure in perfusion, distribution coefficient, and glucose metabolism, which may provide important guidelines for improving individual treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728609     DOI: 10.1097/MNM.0b013e3282e2a880

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

Review 1.  Radionuclide imaging of perfusion and hypoxia.

Authors:  George Laking; Pat Price
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 2.  Hybrid PET-dynamic CECT in the management of breast cancer.

Authors:  Rakesh Kumar; Chandan Jyoti Das
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 3.  Imaging of tumor angiogenesis: functional or targeted?

Authors:  Baris Turkbey; Hisataka Kobayashi; Mikako Ogawa; Marcelino Bernardo; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

4.  Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.

Authors:  Ashley M Groves; Gordon C Wishart; Manu Shastry; Penelope Moyle; Sharon Iddles; Peter Britton; Mathew Gaskarth; Ruth M Warren; Peter J Ell; Kenneth A Miles
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-26       Impact factor: 9.236

5.  Estimating breast tumor blood flow during neoadjuvant chemotherapy using interleaved high temporal and high spatial resolution MRI.

Authors:  Leonidas Georgiou; Nisha Sharma; David A Broadbent; Daniel J Wilson; Barbara J Dall; Anmol Gangi; David L Buckley
Journal:  Magn Reson Med       Date:  2017-04-03       Impact factor: 4.668

6.  Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway.

Authors:  Kui Zhao; Shu-Ye Yang; Shui-Hong Zhou; Meng Jie Dong; Yang-Yang Bao; Hong-Tian Yao
Journal:  Oncol Lett       Date:  2014-02-12       Impact factor: 2.967

7.  Optically measured microvascular blood flow contrast of malignant breast tumors.

Authors:  Regine Choe; Mary E Putt; Peter M Carlile; Turgut Durduran; Joseph M Giammarco; David R Busch; Ki Won Jung; Brian J Czerniecki; Julia Tchou; Michael D Feldman; Carolyn Mies; Mark A Rosen; Mitchell D Schnall; Angela DeMichele; Arjun G Yodh
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

8.  In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT.

Authors:  Natasa Matic; Marcus Ressner; Emilia Wiechec; Karin Roberg
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.